Target intelligence / Profile preview

Lipoprotein-releasing ABC transporter LolCDE (LolCDE)

Target
LolCDE
Molecular classification
ABC transporter, Transporter, ATPase, Membrane protein complex
01

Overview

The Lipoprotein-releasing ABC transporter LolCDE is an essential protein complex located in the inner membrane of Gram-negative bacteria, serving as the initiator of the Lol (Localization of Lipoprotein) pathway (UniProt P0AE08, P0AE12, P0AE10). It is a member of the ATP-binding cassette (ABC) transporter family, composed of the membrane subunits LolC and LolE and the ATPase subunit LolD (PubMed: 30252931). The complex functions by utilizing the energy from ATP hydrolysis to extract lipoproteins from the inner membrane and transfer them to the periplasmic chaperone LolA for transport to the outer membrane (Nature, 2024, 630, 703–709). This process is fundamental for the biogenesis of the bacterial outer membrane and is critical for the viability of Gram-negative pathogens like Escherichia coli and Klebsiella pneumoniae. Because the Lol pathway is absent in Gram-positive bacteria and eukaryotic cells, LolCDE is a highly specific target for narrow-spectrum antibiotics. Recent breakthroughs have identified Lolamycin as a potent inhibitor of LolCDE, demonstrating the ability to selectively target pathogens while sparing the gut microbiome (Nature, 2024, 630, 703–709).

Other names
LolCDE complexLipoprotein localization machineryLolC-LolD-LolE complexLolCDE transporterLolCDE
02

Mechanism of action

Inhibition of the LolCDE complex prevents the ATP-dependent transfer of lipoproteins from the inner membrane to the periplasmic chaperone LolA, thereby disrupting the assembly of the bacterial outer membrane and leading to cell death (Nature, 2024, 630, 703–709).

03

Biological functions

Lipoprotein transportOuter membrane biogenesisCell wall organization
04

Disease associations

Infection
05

Safety considerations

Development of antimicrobial resistance through target mutationsPotential off-target effects on host commensal microbiotaRequirement for high specificity to avoid cross-reactivity with human ABC transporters
06

Interacting drugs

Lolamycin
07

Biomarkers

Bacterial growth inhibitionLipoprotein accumulation in the inner membraneOuter membrane integrity markers

Beyond the preview

Go deeper on Lipoprotein-releasing ABC transporter LolCDE (LolCDE).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lipoprotein-releasing ABC transporter LolCDE (LolCDE).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call